相关期刊:《World Journal of Gastroenterology》《World Journal of Gastrointestinal Pharmacology and Therapeutics》《Open Journal of Gastroenterology》《Journal of Pharmaceutical Analysis》更多>>
Supported by Higher Education Commission Pakistan,No20-1051/R&D/2007
AIMTo study the effect of itopride on gastric accommodation, gastric emptying and drinking capacity in functional dyspepsia (FD). METHODSRandomized controlled trial was conducted to check the effect of itopride on gas...
Background: The efficacy of lubiprostone for chronic constipation has been established through phase III clinical trials. Nevertheless, the continuation of lubiprostone therapy is reportedly difficult due to the devel...
Supported by The Natural Science Foundation of Zhejiang Province of China,No. LY12H29002;Traditional Chinese Medicine Science Foundation of Zhejiang Province of China,No. 2011ZB032
AIM:To evaluate the therapeutic effects of itopride vs other drugs(placebo,domperidone,mosapride) for functional dyspepsia(FD).METHODS:Randomized controlled trials(RCTs) of itopride for FD were retrieved from database...
AIM:To evaluate the effect of prokinetic drugs on electrogastrography(EGG) parameters according to symptomatic changes in patients with functional dyspepsia(FD).METHODS:Seventy-four patients with FD were prospectively...
A specific, precise and stability indicating high-performance thin-layer chromatographic method for simultaneous estimation of pantoprazole sodium and itopride hydrochloride in pharmaceutical formulations was develope...
Supported by the 2004 Research Fund of Wonkwang University
AIM: Itopride is a newly developed prokinetic agent, which enhances gastric motility through both antidopaminergic and anti-acetylcholinesterasic actions. The importance of esophageal motor dysfunction in the pathoge...